Hiroki Nishikawa

12PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiologyMedical genetics (excl. cancer genetics)Metabolic medicineEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 03, 2025
Impact of time-of-day atezolizumab plus bevacizumab combination therapy infusion for unresectable hepatocellular carcinoma: A retrospective multicenter study.

Atsushi Naganuma, Satoru Kakizaki, Takeshi Hatanaka

|Jul 18, 2024
Multicenter study comparing EUS-guided hepaticogastrostomy and ERCP for malignant biliary obstruction in patients with accessible papillae.

Takeshi Ogura, Hirotoshi Ishiwatari, Susumu Hijioka

|Nov 20, 2023
Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.

Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka

|May 31, 2021
Reduced handgrip strength predicts poorer survival in chronic liver diseases: A large multicenter study in Japan.

Hiroki Nishikawa, Makoto Shiraki, Akira Hiramatsu

|Mar 27, 2021
Clinical impact of the finger-circle test in patients with liver diseases.

Hiroki Nishikawa, Kazunori Yoh, Hirayuki Enomoto

|Jan 19, 2021
Severity of liver fibrosis using shear wave elastography is influenced by hepatic necroinflammation in chronic hepatitis patients, but not in cirrhotic patients.

Chikage Nakano, Takashi Nishimura, Toshifumi Tada

Pageof 2